Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Human Glypican 3 Antikörper:
anti-Mouse (Murine) Glypican 3 Antikörper:
anti-Rat (Rattus) Glypican 3 Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Human Monoclonal Glypican 3 Primary Antibody für ICC, IHC (fro) - ABIN335359
Couchman, Ljubimov, Sthanam, Horchar, Hassell: Antibody mapping and tissue localization of globular and cysteine-rich regions of perlecan domain III. in The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1995
Show all 7 Pubmed References
Human Polyclonal Glypican 3 Primary Antibody für CyTOF, FACS - ABIN4899915
Sawada, Yoshikawa, Nobuoka, Shirakawa, Kuronuma, Motomura, Mizuno, Ishii, Nakachi, Konishi, Nakagohri, Takahashi, Gotohda, Takayama, Yamao, Uesaka, Furuse, Kinoshita, Nakatsura: Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma: immunologic evidence and potential for improving overall survival. in Clinical cancer research : an official journal of the American Association for Cancer Research 2012
Show all 3 Pubmed References
Human Polyclonal Glypican 3 Primary Antibody für IHC (p), WB - ABIN4369853
Lai, Sandhu, Yu, Han, Moser, Jackson, Guerrero, Aderca, Isomoto, Garrity-Park, Zou, Shire, Nagorney, Sanderson, Adjei, Lee, Thorgeirsson, Roberts: Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma. in Hepatology (Baltimore, Md.) 2008
Show all 3 Pubmed References
Human Monoclonal Glypican 3 Primary Antibody für ICC, FACS - ABIN969523
Zittermann, Capurro, Shi, Filmus: Soluble glypican 3 inhibits the growth of hepatocellular carcinoma in vitro and in vivo. in International journal of cancer. Journal international du cancer 2010
Show all 2 Pubmed References
Human Polyclonal Glypican 3 Primary Antibody für IHC, ELISA - ABIN1585811
Magistri, Leonard, Tang, Chan, Lee, Sicklick: The glypican 3 hepatocellular carcinoma marker regulates human hepatic stellate cells via Hedgehog signaling. in The Journal of surgical research 2014
Human Monoclonal Glypican 3 Primary Antibody für CyTOF, FACS - ABIN4899916
Haupt, Murali, Mun, Teplyuk, Mei, Stein, van Wijnen, Nurcombe, Cool: The heparan sulfate proteoglycan (HSPG) glypican-3 mediates commitment of MC3T3-E1 cells toward osteogenesis. in Journal of cellular physiology 2009
Cow (Bovine) Polyclonal Glypican 3 Primary Antibody für IHC, WB - ABIN2780199
Boily, Saikali, Sinnett: Methylation analysis of the glypican 3 gene in embryonal tumours. in British journal of cancer 2004
Show all 2 Pubmed References
Glypican-3 overexpression in Wilms tumor correlates with poor overall survival.
glypican-3 has a role in HBV-related hepatocellular carcinoma
MOSPD1 is a possible candidate gene for DORV (zeige GDF1 Antikörper), probably in combination with GPC3. Further studies of the combined functions of MOSPD1 and GPC3 are needed, and identification of additional patients with MOSPD1 and GPC3 duplication should be pursued
Glypican-3 is correlated with the clinical malignant behavior of hepatocellular carcinoma and its phenotype changes from positive to negative during tumor cells differentia- tion.
The diagnostic sensitivity for hepatocellular carcinoma increased to 72.8% (206 of the 283) when glypican 3 was combined with alpha-fetoprotein (zeige AFP Antikörper).
The lncRNA glypican 3 antisense transcript 1 (GPC3-AS1 (zeige PTGDR Antikörper)) has been reported to be a potential biomarker for hepatocellular carcinoma (HCC (zeige FAM126A Antikörper)) screening. We observed a significant upregulation of GPC3-AS1 (zeige PTGDR Antikörper) in HCC (zeige FAM126A Antikörper). Increased expression of GPC3-AS1 (zeige PTGDR Antikörper) was associated with alpha-fetoprotein (zeige AFP Antikörper), tumor size, microvascular invasion, encapsulation, Barcelona Clinic Liver Cancer stage, and worse prognosis of HCC (zeige FAM126A Antikörper) patients.
study provides the first evidence that GPC3 can modulate the PCSK9 (zeige PCSK9 Antikörper) extracellular activity as a competitive binding partner to the LDLR (zeige LDLR Antikörper) in HepG2 cells.
By subsequent Sanger sequencing of genomic DNA we could map the chromosomal break points to define a deletion size of 43,617 bp including exons 5 and 6 of the GPC3 gene.
This is the first study in which the optimal HLA-A*0201 GPC3 epitopes were screened from a large number of candidates predicted by three software. The optimized HLA-A*0201 GPC3 peptides will provide new epitope candidates for hepatocellular carcinoma (HCC (zeige FAM126A Antikörper)) immunotherapy.
GPC3 and KRT19 (zeige KRT19 Antikörper) overexpression are associated with carcinogenesis, progression, and poor prognosis in patients with PDAC and a valuable biomarker for diagnosis of PDAC.
Data show that notum (zeige NOTUM Antikörper) and glypican-1 (zeige GPC1 Antikörper) and glypican-3 gene expression during colorectal cancer (CRC (zeige SCRIB Antikörper)) development and present evidence to suggest them as potential new biomarkers of CRC (zeige SCRIB Antikörper) pathogenesis.
Coupling of pGPC3 to liposomes was essential for effective priming of GPC3-specific CTLs.
The expression of GPC-3 was altered by DEN treatment.
Data suggest that GPC3 down-regulates hepatocyte proliferation by binding to hedgehog (zeige SHH Antikörper) (HH) and down-regulating the HH signaling pathway and binding with CD81 (zeige CD81 Antikörper), thus making it unavailable to bind to Hhex (zeige HHEX Antikörper) and causing its nuclear translocation.
Finding represents a rare four layer genomic overlap consisting of growth associated quantitative trait locus (QTL), body mass associated Gpc3 gene, highly conserved miRNA gene and mature miRNA seed SNP identified in the lean mouse.
Hepatocyte overexpression of GPC3 suppresses hepatocyte proliferation and liver regeneration and alters gene expression profiles.
glypican-3 is involved in the recruitment of M2-polarized tumor-associated macrophages in hepatocellular carcinoma
GPC3 inhibits the PI3K/Akt (zeige AKT1 Antikörper) anti-apoptotic pathway while it stimulates the p38MAPK (zeige MAPK14 Antikörper) stress-activated one in murine mammary adenocarcinoma LM3 cells
Gpc3 function in development of Simpson-Golabi-Behmel syndrome is IGF-independent
GPC3 knockout mice exhibit alterations in the Wnt (zeige WNT2 Antikörper) signaling pathway, which is also associated with the regulation of cell proliferation
Cell surface heparan sulfate proteoglycans are composed of a membrane-associated protein core substituted with a variable number of heparan sulfate chains. Members of the glypican-related integral membrane proteoglycan family (GRIPS) contain a core protein anchored to the cytoplasmic membrane via a glycosyl phosphatidylinositol linkage. These proteins may play a role in the control of cell division and growth regulation. The protein encoded by this gene can bind to and inhibit the dipeptidyl peptidase activity of CD26, and it can induce apoptosis in certain cell types. Deletion mutations in this gene are associated with Simpson-Golabi-Behmel syndrome, also known as Simpson dysmorphia syndrome. Alternative splicing results in multiple transcript variants.
, glypican proteoglycan 3
, heparan sulphate proteoglycan
, intestinal protein OCI-5
, secreted glypican-3
, defective in Simpson-Golabi-Behmel overgrowth syndrome
, proteoglycan GPC3
, Intestinal protein OCI-5